# Use of Cysteamine in the Treatment of Cystinosis

> **NCT00359684** · — · RECRUITING · sponsor: **National Human Genome Research Institute (NHGRI)** · enrollment: 330 (estimated)

## Conditions studied

- Cystinosis

## Interventions

- **DRUG:** Cysteamine

## Key facts

- **NCT ID:** NCT00359684
- **Lead sponsor:** National Human Genome Research Institute (NHGRI)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 1979-01-04
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 330 (ESTIMATED)
- **Last updated:** 2026-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00359684

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00359684, "Use of Cysteamine in the Treatment of Cystinosis". Retrieved via AI Analytics 2026-09-01 from https://api.ai-analytics.org/clinical/NCT00359684. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*